Epidemiologic analyses of risk factors, risk indicators, risk markers, and causal factors: The example of albuminuria and the risk of cardiovascular disease in diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 31, Issue 3, 2002, Pages 537-551

  Gerstein, Hertzel C ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BIRTH WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC BRONCHITIS; DIABETES MELLITUS; ENTERITIS; EPIDEMIOLOGICAL DATA; ETHNOLOGY; GENE MUTATION; HUMAN; HYPERTENSION; OBESITY; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK FACTOR; SOCIOECONOMICS;

ALBUMINURIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 0036713823     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(02)00019-1     Document Type: Review

References (22)

1. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
2. What is diabetes?
3. Economic consequences of diabetes mellitus in the US in 1997
4. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study
5. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
6. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
7. Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE study
8. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO HOPE substudy
9. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus
10. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
11. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus
12. Microalbuminuria as predictor of increased mortality in elderly people
13. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria
14. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus
15. Measures of association
16. The environment and disease: Association or causation?
17. Cause
18. How to read a clinical journal
19. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
20. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
21. Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points
22. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias